La Jolla Pharma (LJPC) a Top Pick at Chardan Capital Markets Into Data
Tweet Send to a Friend
Chardan Capital Markets analyst Gbola Amusa called La Jolla Pharma (NASDAQ: LJPC) a top pick for 2017 heading into
LJPC-501's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
LJPC-501's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
